TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$21.39 USD
+0.89 (4.34%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $21.36 -0.03 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Earnings News For TGTX
-
TG Therapeutics: Q1 Earnings Snapshot
-
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
-
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
TG Therapeutics: Q4 Earnings Snapshot
-
TG Therapeutics: Q4 Earnings Snapshot
-
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
-
Will TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know
-
TG Therapeutics: Q3 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
-
TG Therapeutics (TGTX) Reports Q2 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q2 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
-
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q1 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
-
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q4 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results
-
TG Therapeutics (TGTX) Reports Q3 Loss, Lags Revenue Estimates
-
TG Therapeutics: Q3 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
-
TG Therapeutics (TGTX) Reports Q2 Loss, Tops Revenue Estimates
-
TG Therapeutics: Q2 Earnings Snapshot
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results